Skip to main content
Caplight Logo









Edesa Biotech Inc

Edesa Biotech Inc

Public

Edesa Biotech Inc is now publicly traded

The data on this page reflects Edesa Biotech Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jun 26, 2026

Total Funding Raised

$3.5M

Company Overview

Edesa Biotech Inc is a clinical-stage biopharmaceutical company that develops targeted therapies for inflammatory and immune-related diseases.

Sector

Healthcare

AI Layer

Non-AI

Keywords

biopharmaceuticalmonoclonal antibodyacute respiratory distress syndromeARDSclinical stagedrug developmentclinical trialinflammatory diseasebiotechdrug pipelineallergic contact dermatitistherapeuticout-licensingbiologicsnon-dilutive funding

Edesa Biotech Inc Comparables

Compare Edesa Biotech Inc with similar companies based on industry and business-model similarity.

No public comparables are available for Edesa Biotech Inc. Request access to learn about comparables coverage.

Request access

Edesa Biotech Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJun 26, 2026

Key People

Founding team and executive leadership

Peter W.

Chief Financial Officer

Executive Team

Edesa Biotech Inc Filings

Explore SEC and related filing metadata, where available.

Edesa Biotech Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersCanada
Employee Range22
Year Founded2015
Last FundingJun 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?